Large gap with delayed quotes
|
Last quote
11/04/2025
-
02:00:00
|
Bid
11/04/2025 -
13:00:12
|
Bid Volume |
Ask
11/04/2025 -
13:00:12
|
Ask Volume |
|---|---|---|---|---|
|
150.17
+1.11
(
+0.74% )
|
143.91
|
100 |
179.85
|
100 |
Analysis date: 31.10.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 01.07.2025.
Interest
Weak
Weak
Two stars since 28.10.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 28.10.2025 at a price of 151.57.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 23.09.2025.
4wk Rel Perf
9.25%
9.25%
The four-week dividend-adjusted overperformance versus SP500 is 9.25%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.39%.
Mkt Cap in $bn
8.39
8.39
With a market capitalization >$8bn, REPLIGEN is considered a large-cap stock.
G/PE Ratio
0.76
0.76
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
54.25
54.25
The estimated PE is for the year 2027.
LT Growth
41.02%
41.02%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
128
128
For 1% of index variation, the stock varies on average by 1.28%.
Correlation
0.49
0.49
48.70% of stock movements are explained by index variations.
Value at Risk
70.22
70.22
The value at risk is estimated at USD 70.22. The risk is therefore 47.11%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.11.2019
22.11.2019